Abiopharma

🔍 Hollub Vicki A. (Director)

Company: LOCKHEED MARTIN CORP (LMT)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 416 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 415.60 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 416 shares of Phantom Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,504.05 | transaction_form_type: 4 | Footnotes: F2, F2, F1, F1, F3
• Holds 2,525 shares of Phantom Stock Units (Derivative)
  Date: 2026-04-01 | Code: H | shares_owned_after: 2,525.33 | Footnotes: F2, F4, F4, F3

Footnotes:

• F1: The Reporting Person received a distribution of 415.602015 shares of LMT stock in accordance with an election under the Lockheed Martin Corporation Amended and Restated Directors Equity Plan, in settlement of an equal number of phantom stock units held under the Plan. A fractional share of the Reporting Person's phantom stock units (0.602015) was settled in cash.
• F2: Phantom stock units convert to common stock on a one-for-one basis.
• F3: Holdings as of reportable transaction date include additional acquisitions through dividend reinvestment.
• F4: The information pertains to previously acquired phantom stock units under the Lockheed Martin Corporation Directors Deferred Compensation Plan exempt under Section 16(b) which will be settled upon the Reporting Person's retirement or termination of service.